Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2023

Open Access 01-12-2023 | Atrial Septal Defect | Research

Assessment of degradability and endothelialization of modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluders over time in vivo

Authors: Jun Chen, Yumei Xie, Yifan Li, Xianmiao Chen, Mingjuan Fu, Yanfen Liu, Zhiwei Zhang

Published in: Journal of Cardiothoracic Surgery | Issue 1/2023

Login to get access

Abstract

Objective

To evaluate the fiber-degradation and endothelialization of a modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluder for a long time in vivo.

Methods

A total of 57 New Zealand rabbits were selected to establish the vasculature implantation model, which would be used to characterize the mechanical properties and pathological reaction of PLLA filaments (a raw polymer of ASD occluder). In total, 27 Experimental piglets were used to create the ASD model for the catheter implantation of PLLA ASD occluders. Then, X-ray imaging, transthoracic echocardiography, histopathology, and scanning electron microscope (SEM) were performed in the experimental animals at 3, 6, 12, and 24 months after implantation.

Results

In the rabbit models, the fibrocystic grade was 0 and the inflammatory response was grade 2 at 6 months after vasculature implantation of the PLLA filaments. The mass loss of PLLA filaments increased appreciably with the increasing duration of implantation, but their mechanical strength was decreased without broken. In the porcine models, the cardiac gross anatomy showed that all PLLA ASD occluders were stable in the interatrial septum without any vegetation or thrombus formation. At 24 months, the occluders had been embedded into endogenous host tissue nearly. Pathological observations suggested that the occluders degraded gradually without complications at different periods. SEM showed that the occluders were endothelialized completely and essentially became an integral part of the body over time.

Conclusion

In the animal model, the modified PLLA ASD occluders exhibited good degradability and endothelialization in this long-term follow-up study.
Literature
1.
go back to reference Bissessor N. Current perspectives in percutaneous atrial septal defect closure devices. Med Devices (Auckl). 2015;8:297–303.PubMed Bissessor N. Current perspectives in percutaneous atrial septal defect closure devices. Med Devices (Auckl). 2015;8:297–303.PubMed
2.
go back to reference Olasinska-Wisniewska A, Grygier M. Antithrombotic/Antiplatelet treatment in Transcatheter Structural Cardiac Interventions-PFO/ASD/LAA occluder and Interatrial Shunt Devices. Front Cardiovasc Med. 2019;6:75.CrossRefPubMedPubMedCentral Olasinska-Wisniewska A, Grygier M. Antithrombotic/Antiplatelet treatment in Transcatheter Structural Cardiac Interventions-PFO/ASD/LAA occluder and Interatrial Shunt Devices. Front Cardiovasc Med. 2019;6:75.CrossRefPubMedPubMedCentral
3.
go back to reference Lu W, Ouyang W, Wang S, et al. A novel totally biodegradable device for effective atrial septal defect closure: a 2-year study in sheep. J Interv Cardiol. 2018;31(6):841–8.CrossRefPubMed Lu W, Ouyang W, Wang S, et al. A novel totally biodegradable device for effective atrial septal defect closure: a 2-year study in sheep. J Interv Cardiol. 2018;31(6):841–8.CrossRefPubMed
4.
go back to reference Shi D, Kang Y, Zhang G, et al. Biodegradable atrial septal defect occluders: a current review. Acta Biomater. 2019;96:68–80.CrossRefPubMed Shi D, Kang Y, Zhang G, et al. Biodegradable atrial septal defect occluders: a current review. Acta Biomater. 2019;96:68–80.CrossRefPubMed
5.
go back to reference Lu A, Petit E, Jelonek K, et al. Self-assembled micelles prepared from bio-based hydroxypropyl methyl cellulose and polylactide amphiphilic block copolymers for anti-tumor drug release. Int J Biol Macromol. 2020;154:39–47.CrossRefPubMed Lu A, Petit E, Jelonek K, et al. Self-assembled micelles prepared from bio-based hydroxypropyl methyl cellulose and polylactide amphiphilic block copolymers for anti-tumor drug release. Int J Biol Macromol. 2020;154:39–47.CrossRefPubMed
6.
go back to reference Cao S, Shao J, Xia Y, et al. Molecular Programming of Biodegradable Nanoworms via Ionically Induced morphology switch toward asymmetric therapeutic carriers. Small. 2019;15(38):e1901849.CrossRefPubMed Cao S, Shao J, Xia Y, et al. Molecular Programming of Biodegradable Nanoworms via Ionically Induced morphology switch toward asymmetric therapeutic carriers. Small. 2019;15(38):e1901849.CrossRefPubMed
7.
go back to reference Evgenidou E, Ofrydopoulou A, Malesic-Eleftheriadou N, et al. New insights into transformation pathways of a mixture of cytostatic drugs using Polyester-TiO2 films: identification of intermediates and toxicity assessment. Sci Total Environ. 2020;741:140394.CrossRefPubMed Evgenidou E, Ofrydopoulou A, Malesic-Eleftheriadou N, et al. New insights into transformation pathways of a mixture of cytostatic drugs using Polyester-TiO2 films: identification of intermediates and toxicity assessment. Sci Total Environ. 2020;741:140394.CrossRefPubMed
8.
go back to reference Pacharra S, Ortiz R, McMahon S, et al. Surface patterning of a novel PEG-functionalized poly-l-lactide polymer to improve its biocompatibility: applications to bioresorbable vascular stents. J Biomed Mater Res B Appl Biomater. 2019;107(3):624–34.CrossRefPubMed Pacharra S, Ortiz R, McMahon S, et al. Surface patterning of a novel PEG-functionalized poly-l-lactide polymer to improve its biocompatibility: applications to bioresorbable vascular stents. J Biomed Mater Res B Appl Biomater. 2019;107(3):624–34.CrossRefPubMed
9.
go back to reference Liang X, Gao J, Xu W, et al. Structural mechanics of 3D-printed poly(lactic acid) scaffolds with tetragonal, hexagonal and wheel-like designs. Biofabrication. 2019;11(3):035009.CrossRefPubMed Liang X, Gao J, Xu W, et al. Structural mechanics of 3D-printed poly(lactic acid) scaffolds with tetragonal, hexagonal and wheel-like designs. Biofabrication. 2019;11(3):035009.CrossRefPubMed
10.
go back to reference Vahl TP, Gasior P, Gongora CA, et al. Four-year polymer biocompatibility and vascular healing profile of a novel ultrahigh molecular weight amorphous PLLA bioresorbable vascular scaffold: an OCT study in healthy porcine coronary arteries. EuroIntervention. 2016;12(12):1510–8.CrossRefPubMed Vahl TP, Gasior P, Gongora CA, et al. Four-year polymer biocompatibility and vascular healing profile of a novel ultrahigh molecular weight amorphous PLLA bioresorbable vascular scaffold: an OCT study in healthy porcine coronary arteries. EuroIntervention. 2016;12(12):1510–8.CrossRefPubMed
11.
go back to reference Li BN, Xie YM, Xie ZF, Chen XM, Zhang G, Zhang DY, Liu XD, Zhang ZW. Study of biodegradable occluder of atrial septal defect in a porcine model. Catheter Cardiovasc Interv. 2019;93(1):E38–E45.CrossRefPubMed Li BN, Xie YM, Xie ZF, Chen XM, Zhang G, Zhang DY, Liu XD, Zhang ZW. Study of biodegradable occluder of atrial septal defect in a porcine model. Catheter Cardiovasc Interv. 2019;93(1):E38–E45.CrossRefPubMed
12.
go back to reference Xie ZF, Wang SS, Zhang ZW, Zhuang J, Liu XD, Chen XM, Zhang G, Zhang DA, Novel-Design. Poly-L-Lactic acid biodegradable device for Closure of Atrial Septal defect: long-term results in Swine. Cardiology. 2016;135(3):179–87. Epub 2016 Jul 12. PMID: 27398912.CrossRefPubMed Xie ZF, Wang SS, Zhang ZW, Zhuang J, Liu XD, Chen XM, Zhang G, Zhang DA, Novel-Design. Poly-L-Lactic acid biodegradable device for Closure of Atrial Septal defect: long-term results in Swine. Cardiology. 2016;135(3):179–87. Epub 2016 Jul 12. PMID: 27398912.CrossRefPubMed
13.
go back to reference Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997;42(4):388–93.CrossRefPubMed Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn. 1997;42(4):388–93.CrossRefPubMed
14.
go back to reference Pranata R, Yonas E, Deka H, Vania R, July J. Stent-assisted coiling of intracranial Aneurysms using a Nitinol-Based stent (Neuroform Atlas): a systematic review and Meta-analysis. Cardiovasc Intervent Radiol. 2020;43(7):1049–61.CrossRefPubMed Pranata R, Yonas E, Deka H, Vania R, July J. Stent-assisted coiling of intracranial Aneurysms using a Nitinol-Based stent (Neuroform Atlas): a systematic review and Meta-analysis. Cardiovasc Intervent Radiol. 2020;43(7):1049–61.CrossRefPubMed
15.
go back to reference Dhondt E, Vanlangenhove P, De Man M, Huyck L, Defreyne L. No advantage of expanded polytetrafluoroethylene and Fluorinated Ethylene propylene-covered stents over uncovered Nitinol Stents for Percutaneous palliation of malignant infrahilar biliary obstruction: results of a single-center prospective randomized trial. J Vasc Interv Radiol. 2020;31(1):82–92.CrossRefPubMed Dhondt E, Vanlangenhove P, De Man M, Huyck L, Defreyne L. No advantage of expanded polytetrafluoroethylene and Fluorinated Ethylene propylene-covered stents over uncovered Nitinol Stents for Percutaneous palliation of malignant infrahilar biliary obstruction: results of a single-center prospective randomized trial. J Vasc Interv Radiol. 2020;31(1):82–92.CrossRefPubMed
16.
go back to reference Lin C, Liu L, Liu Y, Leng J. Recent developments in next-generation occlusion devices. Acta Biomater. 2021;128:100–19.CrossRefPubMed Lin C, Liu L, Liu Y, Leng J. Recent developments in next-generation occlusion devices. Acta Biomater. 2021;128:100–19.CrossRefPubMed
17.
go back to reference Esmaeili A, Behnke-Hall K, Schrewe R, Schranz D. Percutaneous closure of perimembranous ventricular septal defects utilizing almost ideal Amplatzer Duct Occluder II: why limitation in sizes? Congenit Heart Dis. 2019;14(3):389–95.CrossRefPubMed Esmaeili A, Behnke-Hall K, Schrewe R, Schranz D. Percutaneous closure of perimembranous ventricular septal defects utilizing almost ideal Amplatzer Duct Occluder II: why limitation in sizes? Congenit Heart Dis. 2019;14(3):389–95.CrossRefPubMed
18.
go back to reference Fabi SG, Weiss R, Weinkle SH. Absorbable suspension sutures: recommendations for Use in a Multimodal Nonsurgical Approach to Facial Rejuvenation. J Drugs Dermatol. 2021;20(1):23–9.CrossRefPubMed Fabi SG, Weiss R, Weinkle SH. Absorbable suspension sutures: recommendations for Use in a Multimodal Nonsurgical Approach to Facial Rejuvenation. J Drugs Dermatol. 2021;20(1):23–9.CrossRefPubMed
19.
go back to reference Hasan A, Soliman S, El Hajj F, Tseng YT, Yalcin HC, Marei HE. Fabrication and in Vitro characterization of a tissue Engineered PCL-PLLA Heart Valve. Sci Rep. 2018;8(1):8187.CrossRefPubMedPubMedCentral Hasan A, Soliman S, El Hajj F, Tseng YT, Yalcin HC, Marei HE. Fabrication and in Vitro characterization of a tissue Engineered PCL-PLLA Heart Valve. Sci Rep. 2018;8(1):8187.CrossRefPubMedPubMedCentral
20.
go back to reference Wu WY, Li BW, Liu YH, Wang XZ. Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52(3):564–9.PubMed Wu WY, Li BW, Liu YH, Wang XZ. Beijing Da Xue Xue Bao Yi Xue Ban. 2020;52(3):564–9.PubMed
21.
go back to reference Kian LK, Saba N, Jawaid M, Sultan MTH. A review on processing techniques of bast fibers nanocellulose and its polylactic acid (PLA) nanocomposites. Int J Biol Macromol. 2019;121:1314–28.CrossRefPubMed Kian LK, Saba N, Jawaid M, Sultan MTH. A review on processing techniques of bast fibers nanocellulose and its polylactic acid (PLA) nanocomposites. Int J Biol Macromol. 2019;121:1314–28.CrossRefPubMed
22.
go back to reference Wu J, Gui X, Jiang H, et al. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34(5):630–6.PubMed Wu J, Gui X, Jiang H, et al. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2020;34(5):630–6.PubMed
23.
go back to reference Oberhauser JP, Hossainy S, Rapoza RJ. Design principles and performance of bioresorbable polymeric vascular scaffolds. EuroIntervention. 2009;5 Suppl F:F15–F22. Oberhauser JP, Hossainy S, Rapoza RJ. Design principles and performance of bioresorbable polymeric vascular scaffolds. EuroIntervention. 2009;5 Suppl F:F15–F22.
24.
go back to reference Zhu YF, Huang XM, Cao J, et al. Animal experimental study of the fully biodegradable atrial septal defect (ASD) occluder. J Biomed Biotechnol. 2012;2012:735989.CrossRefPubMedPubMedCentral Zhu YF, Huang XM, Cao J, et al. Animal experimental study of the fully biodegradable atrial septal defect (ASD) occluder. J Biomed Biotechnol. 2012;2012:735989.CrossRefPubMedPubMedCentral
25.
go back to reference Li BN, Xie YM, Xie ZF, et al. Study of biodegradable occluder of atrial septal defect in a porcine model. Catheter Cardiovasc Interv. 2019;93(1):E38–E45.CrossRefPubMed Li BN, Xie YM, Xie ZF, et al. Study of biodegradable occluder of atrial septal defect in a porcine model. Catheter Cardiovasc Interv. 2019;93(1):E38–E45.CrossRefPubMed
26.
go back to reference Oyama HT, Tanishima D, Ogawa R. Biologically safe poly(l-lactic acid) blends with tunable degradation rate: microstructure, degradation mechanism, and Mechanical Properties. Biomacromolecules. 2017;18(4):1281–92.CrossRefPubMed Oyama HT, Tanishima D, Ogawa R. Biologically safe poly(l-lactic acid) blends with tunable degradation rate: microstructure, degradation mechanism, and Mechanical Properties. Biomacromolecules. 2017;18(4):1281–92.CrossRefPubMed
27.
go back to reference Lin S, Dong P, Zhou C, et al. Degradation modeling of poly-l-lactide acid (PLLA) bioresorbable vascular scaffold within a coronary artery. Nanotechnol Rev. 2020;9(1):1217–26.CrossRefPubMedPubMedCentral Lin S, Dong P, Zhou C, et al. Degradation modeling of poly-l-lactide acid (PLLA) bioresorbable vascular scaffold within a coronary artery. Nanotechnol Rev. 2020;9(1):1217–26.CrossRefPubMedPubMedCentral
Metadata
Title
Assessment of degradability and endothelialization of modified poly L-lactic acid (PLLA) atrial septal defect (ASD) occluders over time in vivo
Authors
Jun Chen
Yumei Xie
Yifan Li
Xianmiao Chen
Mingjuan Fu
Yanfen Liu
Zhiwei Zhang
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2023
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-023-02401-3

Other articles of this Issue 1/2023

Journal of Cardiothoracic Surgery 1/2023 Go to the issue